Literature DB >> 10426426

Antimicrobial peptides in insects; structure and function.

P Bulet1, C Hetru, J L Dimarcq, D Hoffmann.   

Abstract

Antimicrobial peptides appear to be ubiquitous and multipotent components of the innate immune defense arsenal used by both prokaryotic and eukaryotic organisms. During the past 15 years a multitude of these peptides have been isolated largely from insects. In spite of great differences in size, amino acid composition and structure, most of the antimicrobial peptides from insects can be grouped into one of three categories. The largest category in number contains peptides with intramolecular disulfide bonds forming hairpin-like beta-sheets or alpha-helical-beta-sheet mixed structures. The second most important group is composed of peptides forming amphipathic alpha-helices. The third group comprises peptides with an overrepresentation in proline and/or glycine residues. In general, the insect antimicrobial peptides have a broad range of activity and are not cytotoxic. Despite a wealth of information on structural requirements for their antimicrobial activity, the mode of action of these peptides is not yet fully understood. However, some data suggest the existence of two types of mode of action: 1. through peptide-lipid interaction or 2. through receptor-mediated recognition processes. This review presents the main results obtained during the last four years in the field of antimicrobial peptides from insects with a special focus on the proline-rich and cysteine-rich peptides.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10426426     DOI: 10.1016/s0145-305x(99)00015-4

Source DB:  PubMed          Journal:  Dev Comp Immunol        ISSN: 0145-305X            Impact factor:   3.636


  218 in total

Review 1.  Genetics of mosquito vector competence.

Authors:  B T Beerntsen; A A James; B M Christensen
Journal:  Microbiol Mol Biol Rev       Date:  2000-03       Impact factor: 11.056

2.  Insect peptides with improved protease-resistance protect mice against bacterial infection.

Authors:  L Otvos; K Bokonyi; I Varga; B I Otvos; R Hoffmann; H C Ertl; J D Wade; A M McManus; D J Craik; P Bulet
Journal:  Protein Sci       Date:  2000-04       Impact factor: 6.725

3.  Evidence for recurrent paralogous gene conversion and exceptional allelic divergence in the Attacin genes of Drosophila melanogaster.

Authors:  B P Lazzaro; A G Clark
Journal:  Genetics       Date:  2001-10       Impact factor: 4.562

Review 4.  NF-kappaB in the immune response of Drosophila.

Authors:  Charles Hetru; Jules A Hoffmann
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-10-07       Impact factor: 10.005

5.  The GATA factor Serpent is required for the onset of the humoral immune response in Drosophila embryos.

Authors:  T O Tingvall; E Roos; Y Engström
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-06       Impact factor: 11.205

Review 6.  Mammalian antibiotic peptides.

Authors:  P Síma; I Trebichavský; K Sigler
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

7.  Antiviral and antitumor peptides from insects.

Authors:  Sergey Chernysh; S I Kim; G Bekker; V A Pleskach; N A Filatova; V B Anikin; V G Platonov; Philippe Bulet
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-16       Impact factor: 11.205

8.  Critical evaluation of the role of the Toll-like receptor 18-Wheeler in the host defense of Drosophila.

Authors:  Petros Ligoxygakis; Philippe Bulet; Jean-Marc Reichhart
Journal:  EMBO Rep       Date:  2002-07       Impact factor: 8.807

9.  Antiviral drug discovery strategy using combinatorial libraries of structurally constrained peptides.

Authors:  Eléonore Real; Jean-Christophe Rain; Véronique Battaglia; Corinne Jallet; Pierre Perrin; Noël Tordo; Peggy Chrisment; Jacques D'Alayer; Pierre Legrain; Yves Jacob
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

Review 10.  Diversity in penaeidin antimicrobial peptide form and function.

Authors:  Brandon J Cuthbertson; Leesa J Deterding; Jason G Williams; Kenneth B Tomer; Kizee Etienne; Perry J Blackshear; Erika E Büllesbach; Paul S Gross
Journal:  Dev Comp Immunol       Date:  2007-08-03       Impact factor: 3.636

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.